- Generic name
- Glimepiride
- Strength
- 2 mg
- Dosage form
- Tablet
- Manufactured by
- Ad-din Pharmaceuticals Ltd.
Glaryl 2 Tablet
About Glaryl 2 Tablet
Glaryl 2 comes as a tablet with 2 mg of Glimepiride, from Ad-din Pharmaceuticals Ltd. It may also be prescribed together with metformin when diet, exercise and either medicine alone are not enough.
There are 41 brands of Glimepiride listed in Bangladesh. The lowest listed price is Mepid 1 mg Tablet at ৳ 2.51 per unit.
What is Glaryl 2 Tablet?
Glaryl 2 comes as a tablet with 2 mg of Glimepiride, from Ad-din Pharmaceuticals Ltd. It can also be used together with metformin when either medicine alone, along with diet and exercise, does not give adequate control. It works by helping the pancreas release insulin and by improving how the body responds to it, which lowers blood glucose. The dose and how often you take it are decided by your doctor based on your blood sugar tests.
Uses of Glaryl 2
It may also be prescribed together with metformin when diet, exercise and either medicine alone are not enough. It is not suitable for insulin dependent (type I) diabetes, diabetic ketoacidosis or diabetic coma. Only a doctor can decide whether it suits a particular patient. Your doctor will decide if this medicine is right for you.
How to use Glaryl 2
The aim is to use the lowest amount that keeps your blood sugar under control. Glaryl 2 is taken by mouth. Swallow the tablet with water. Ask your pharmacist if you are unsure how to take it. The doctor decides the dose, how often you take it and for how long, based on your blood sugar results.
Side effects of Glaryl 2
Possible side effects include low blood sugar (hypoglycaemia), temporary vision problems, nausea, vomiting, diarrhoea, abdominal pain, hives, and a fall in blood pressure. Report any side effects to your doctor or pharmacist. Tell your doctor if you notice any of these, and seek help quickly for signs of low blood sugar. Tell your doctor if any of these bother you or do not go away.
Safety and precautions
Do not take this medicine if you are allergic to Glimepiride, other sulfonylureas, or sulfonamides. People planning a pregnancy should inform their doctor. Ask your doctor about any precautions.
Frequently asked questions
Why is Glaryl 2 prescribed?
It may also be prescribed together with metformin when diet, exercise and either medicine alone are not enough. It is not suitable for insulin dependent (type I) diabetes, diabetic ketoacidosis or diabetic coma.
How is Glaryl 2 used?
The aim is to use the lowest amount that keeps your blood sugar under control. Glaryl 2 is taken by mouth.
What should I watch for while using Glaryl 2?
Possible side effects include low blood sugar (hypoglycaemia), temporary vision problems, nausea, vomiting, diarrhoea, abdominal pain, hives, and a fall in blood pressure. Report any side effects to your doctor or pharmacist.
Is Glaryl 2 safe for everyone?
Do not take this medicine if you are allergic to Glimepiride, other sulfonylureas, or sulfonamides. People planning a pregnancy should inform their doctor.
Indications
- Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
- Glimepiride may be used concomitantly with metformin when diet, exercise, and Glimepiride or metformin alone does not result in adequate glycaemic control. ... Read more
- Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
- Glimepiride may be used concomitantly with metformin when diet, exercise, and Glimepiride or metformin alone does not result in adequate glycaemic control.
- Glimepiride is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycaemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycaemic agent.
- Combined use of Glimepiride and insulin may increase the potential for hypoglycaemia.
Pharmacology
Dosage & Administration
Initial dose and dose titration: the usual initial dose is 1 mg once daily, if necessary, the daily dose can be increased. Any increase can be based on regular blood sugar monitoring, and should be gradual, i.e., at intervals of 1 to 2 weeks, and carried out stepwise, as follows: 1 mg -> 2 mg -> 3 mg -> 4 mg -> 6 mg.
Dose in patients with well controlled diabetes: the usual dose range in patients with well controlled diabetes is 1 to 4 mg daily.
Distribution of doses: Timing and distribution of doses are decided by the physician, in consideration of the patient's current life-style. Normally, a single daily dose is sufficient. This should be taken immediately before a substantial breakfast or if none is taken immediately before the first main meal. It is very important not to skip meals after taking the drug.
Secondary dosage adjustment: As control of diabetes improves, sensitivity to insuiin increases; therefore, Glimepiride requirement may fall as treatment proceeds. To avoid hypoglycaemia, timely dose reduction or cessation of Glimepiride therapy must be considered. A dose adjustment must also be considered whenever the patient's weight or life-styie changes, or other factors arise which cause an increased susceptibility to hypo or hyperglycaemia.
Changeover from other oral antidiabetics to Glimepiride: There is no exact dosage relationship between Glimepiride and other oral blood sugar lowering agents. When substituting Glimepiride for other such agents, the initial daily dose is 1 mg; this applies even in changeover from maximum dose of other oral blood sugar lowering agents. Any dose increase should be in accordance with guideline given above in 'initial dose and dose titration'. Consideration must be given to the potency and duration of action of the previous blood sugar lowering agent. It may be necessary to interrupt treatment to avoid additive effects which would increase the risk of hypoglycaemia.
Interaction
In addition to insulin and other oral antidiabetic agents, drugs which may potentiate the hypoglycaemic action of Glimepiride include: ACE inhibitors, aminosalicylic acid, anabolic steroids and male sex hormones, azapropazone, chloramphenicol, ciofibrate, coumarin derivatives, cyclophosphamide, disopyramide, fenfluramine, fenyramidol, fibrates, fluconazole, fluoxetine, guanethidine, ifosfamide, MAO-inhibitors, miconazole, oxpentifylline (high dose parenteral), oxyphenbutazone, para-aminosalicylic acid, phenylbutazone, probenecid, quinolones, salicylates, sulphinpyrazone, sulfonamide antibiotics, tetracyclines, tritoqualine, trofosfamide.
Drugs which may attenuate the hypoglycaemic action of Glimepiride include:
- Acetazoiamide, barbiturates, calcium channel blockers, corticosteroids, diazoxide, diuretics, glucagon, isoniazid, laxatives, nicotinic acid (high doses), oestrogens, phenothiazines, phenytoin, progestagens, rifampicin, sympathomimetic agents, thyroid hormones.
- H2 receptor antagonists, beta-blockers, clonidine and reserpine may lead to either potentiation or weakening of the blood-glucose-lowering effect.
- Concomitant treatment with a beta-receptor blocker, clonidine, guanethidine or reserpine may mask the warning symptoms of a hypoglycaemic attack.
- Acute and chronic aicohol intake may either potentiate or attenuate the activity of Glimepiride in an unpredictable fashion.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Glimepiride
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.